(Q40263198)

English

A chimpanzee-origin adenovirus vector expressing the rabies virus glycoprotein as an oral vaccine against inhalation infection with rabies virus

scientific article published on 22 June 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

A chimpanzee-origin adenovirus vector expressing the rabies virus glycoprotein as an oral vaccine against inhalation infection with rabies virus (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

vector-borne disease

0 references

0 references

1 reference

based on heuristic

inferred from title

0 references

object named as

rabies virus

1 reference

based on heuristic

inferred from title

author name string

Dongming Zhou

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Ann Cun

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Yan Li

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Zhiquan Xiang

4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Hildegund C J Ertl

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

publication date

22 June 2006

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Molecular Therapy

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

662-672

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Airborne rabies transmission in a laboratory worker.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.03.027

7 January 2021

Spread of the CVS strain of rabies virus and of the avirulent mutant AvO1 along the olfactory pathways of the mouse after intranasal inoculation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.03.027

7 January 2021

Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.03.027

7 January 2021

Immune effector mechanisms required for protection to rabies virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.03.027

7 January 2021

Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.03.027

7 January 2021

Effect of strain differences on the potency testing of rabies vaccines in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.03.027

7 January 2021

The challenge to provide affordable rabies post-exposure treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.03.027

7 January 2021

Association of HLA and T-cell receptor gene polymorphisms with Semple rabies vaccine-induced autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.03.027

7 January 2021

Adult dogs receiving a rabies booster dose with a recombinant adenovirus expressing rabies virus glycoprotein develop high titers of neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.03.027

7 January 2021

A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.03.027

7 January 2021

Viral recombinant vaccines to the E6 and E7 antigens of HPV-16

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.03.027

7 January 2021

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.03.027

7 January 2021

Vaccine-induced immunity in baboons by using DNA and replication-incompetent adenovirus type 5 vectors expressing a human immunodeficiency virus type 1 gag gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.03.027

7 January 2021

Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.03.027

7 January 2021

Characterization of four new adenovirus serotypes isolated from chimpanzee tissue explants

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.03.027

7 January 2021

Replication-defective vector based on a chimpanzee adenovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.03.027

7 January 2021

Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.03.027

7 January 2021

CpG methylation of a plasmid vector results in extended transgene product expression by circumventing induction of immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.03.027

7 January 2021

Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.03.027

7 January 2021

Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.03.027

7 January 2021

The adenovirus e3 promoter is sensitive to activation signals in human T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.03.027

7 January 2021

Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.03.027

7 January 2021

Influenza: lessons from past pandemics, warnings from current incidents.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.03.027

7 January 2021

The rabies virus glycoprotein determines the distribution of different rabies virus strains in the brain

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.03.027

7 January 2021

Induction of CD8+ T cells to an HIV-1 antigen upon oral immunization of mice with a simian E1-deleted adenoviral vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.03.027

7 January 2021

Monoclonal antibodies to Mokola virus for identification of rabies and rabies-related viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.03.027

7 January 2021

based on heuristic

inferred from DOI database lookup

Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.03.027

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.YMTHE.2006.03.027

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40263198&oldid=1898349185"